跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Altrazide - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Altrazide
Approved
STANDARD
Altrazide
CB Healthcare
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
d1f88d0aa4eb1896
Company
CB Healthcare
Type
Standard
Approval Details
Approval Id
d1f88d0aa4eb1896
Drug Approval Philippines Name
Altrazide
Product Name
Altrazide
Registration Number
DR-XY49099
Brand Name
Altrazide
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Film-Coated Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
CB Healthcare
Importer
Pranish Inc.
Distributor
Pranish Inc.
Issuance Date
29 May 2024
Expiry Date
29 May 2029
Pharmacologic Category
Angiotensin II Receptor Blocker (ARB) and Diuretic
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
d1f88d0aa4eb1896
Type
Standard
Back to Philippines FDA Approvals